| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-12 |
| filingDate |
1990-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f64b79a5fec1a1321008bbe58d7d4008 |
| publicationDate |
1990-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0390114-A2 |
| titleOfInvention |
Suppression of parathyroid hormone synthesis and secretion with vitamin D3 derivatives |
| abstract |
Use of a vitamin D₃ derivative of formula (I):n wherein R₁, R₂ and R₃, which may be the same or different and represent a hydrogen atom or a hydroxyl group; and R₄ is hydrogen or a C₄₋₆ alkyl group that is optionally substituted by a hydroxy group is disclosed for the preparation of a pharmaceutical composition useful for treatment of hyperparathyroidism, particularly secondary hyperparathyroidism. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4011061-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4011061-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03004036-A1 |
| priorityDate |
1989-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |